Search | Médecins Sans Frontières Access Campaign

157 results found

The first batch of the Ad26.ZEBOV / MVA-BN-Filo vaccine, produced by Janssen / Johnson & Johnson, has arrived in Goma, Democratic Republic of Congo. The start of the study is scheduled for November 14th.

Press release |

05 December 2019

MSF response to Gavi announcement on financing of global emergency stockpile of Ebola vaccine

Gavi’s announcement that it will finance the establishment of an emergency stockpile of 500,000 doses of Ebola vaccine is a positive step. MSF calls for a thorough, independent, and transparent estimate of the costs of manufacturing ...

Tags Vaccines Ebola vaccines Gavi, the Vaccine Alliance

In New York, on Word Pneumonia Day 2015 (Nov 12), MSF volunteers attempted to deliver more than $17 million of fake cash - the equivalent of one day of profits from the pneumonia vaccines for Pfizer globally - to Pfizer's CEO Ian Read. The same day, MSF launched a global petition to ask Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumococcal vaccine to $5 dollars per child (for all three doses) in developing countries. Credit: Edwin Torres.

Press release |

27 April 2017

Investors join MSF in calling Pfizer to reduce the price of vaccine against top childhood killer

Tags Vaccines pneumococcal disease vaccines GlaxoSmithKlinePfizer A Fair Shot

In June and July 2016 MSF has been conducting vaccination campaigns in several refugee camps and settlements in Greece, targeting more than 4,600 children under fifteen years of age. This campaign aims at protecting refugee children with 10 antigens and preventing diseases such as pneumonia, which is the leading cause of childhood death. MSF calls on Pfizer and GSK to drop the price of the pneumonia vaccine (PCV) for governments and humanitarian organizations in emergency contexts.

Press release |

14 November 2016

MSF welcomes Pfizer’s pneumonia vaccine price reduction for children in humanitarian emergencies

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccinevaccines GlaxoSmithKlinePfizer

Press release |

11 November 2016

Breaking news: Pfizer drops the price of the pneumonia vaccine for humanitarian organizations

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccinevaccines Pfizer

The vaccination unit of the MSF clinic in Mpoko, the largest IDPs camp in Bangui, Central African Republic. 14 July 2016.

Press release |

20 April 2016

Fight against HIV doomed to fail without urgent focus on West and Central Africa

Tags HIV/AIDS HIV/AIDS antiretroviral medicines

A Medecins Sans Frontieres (MSF) health promoter holds a health education information session for mothers in Aragata village, Chhattisgarh, India.

Press release |

24 March 2016

MSF responds to Indian Health Ministry’s notification on ban of 344 Fixed Dose Combinations Drugs

Tags drug-resistant TB FDCs India

rVSV-EBOV experimental vaccine against Ebola. Photograph by Yann Libessart

Press release |

20 January 2016

MSF reaction to announcement of Merck and Gavi, the Vaccine Alliance for future Ebola outbreak preparedness

Tags Vaccines Ebola vaccines Gavi, the Vaccine AllianceMerck

Vax_CAR_Measles_MagaliDeppen_2015_MSF152051

Press release |

13 January 2016

Central African Republic (CAR): MSF launches vaccination campaign of unprecedented scale

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccinevaccines Pfizer Central African Republic

Press release |

30 November 2015

HIV: Despite better access to treatment, many AIDS patients in African hospitals still die

Tags HIV/AIDS HIV/AIDS antiretroviral medicines World AIDS Day Kenya

Press release |

24 November 2015

MSF reaction to latest UNAIDS report on global progress of scaling up life-saving HIV treatment

Tags HIV/AIDS HIV/AIDS antiretroviral medicines UNAIDSWorld Health Organization

A woman holds a sign at the Stop Stock Outs (SSP) activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015.

Press release |

27 October 2015

South Africa Should Override Patent on Key HIV Medicine After Widespread Stock Out Problem

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicineslopinavir/ritonavir compulsory licencestock out AbbVie Fix the Patent Laws Campaign South Africa

A malaria flare killed dozens in the beginning of 2015 in Ziralo, eastern DRC. Number of cases has not decreased but MSF intervention managed to help decreasing the mortality.

Press release |

23 October 2015

MSF response on WHO guidance on malaria vaccine RTS,S

Tags MalariaResearch and development malaria vaccines World Health Organization

Research article |

02 September 2015

Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries

Tags Vaccines pneumococcal disease vaccines

MSF Expert Client performing a HIV test at the MSF Dipping Tank community testing campaign at Nhletsheni, in Shiselweleni region, south of Swaziland.

Press release |

20 July 2015

MSF response to START trial data showing all people with HIV should be treated immediately

Tags HIV/AIDS HIV/AIDS antiretroviral medicines International AIDS Conference Eswatini

MSF Nurse handing over 3rd line ARTs to a patient living with HIV.

Press release |

20 July 2015

MSF warns successful global HIV response will require bigger emphasis on adherence

Tags HIV/AIDS HIV/AIDS antiretroviral medicines

Press release |

10 June 2015

Drug shortages threaten progress made in the world’s largest HIV programme

Tags Intellectual property and trade drug-resistant TBHIV/AIDStuberculosis antiretroviral medicines access to medicinesstock out South Africa

Campaign asking Pfizer & GSK to drop the prices of pneumonia vaccines down to 5$/child

Press release |

23 April 2015

MSF kicks off global ████ to reduce the price of ████ to $5 in developing countries

Tags Vaccines pneumococcal disease vaccines access to medicines GlaxoSmithKlinePfizer

2013 marked the first time that PCV is being used in South Sudan and one of the first vaccines to be implemented in compliance with the new WHO emergency vaccination recommendations.

Press release |

26 January 2015

MSF responds to Pfizer announcement of pneumococcal vaccine price reduction

Tags Vaccines pneumococcal disease vaccines Gavi, the Vaccine AllianceGlaxoSmithKlinePfizer

Emergency coordinator Anja Wolz (centre) reminds MSF International President Dr Joanne Liu (right) to adjust goggles so that it fits comfortably and securely. Photograph by P.K. Lee

Press release |

07 January 2015

Oxford University begins trial of possible Ebola treatment at MSF Treatment Centre in Liberia

Tags Tropical & neglected diseases Ebola vaccines Oxford University Liberia

Press release |

13 August 2013

As US FDA approves promising new HIV drug dolutegravir, MSF asks when people in developing countries will have access

Tags HIV/AIDS HIV/AIDS antiretroviral medicinesdolutegravir

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF response to Gavi announcement on financing of global emergency stockpile of Ebola vaccine

Investors join MSF in calling Pfizer to reduce the price of vaccine against top childhood killer

MSF welcomes Pfizer’s pneumonia vaccine price reduction for children in humanitarian emergencies

Breaking news: Pfizer drops the price of the pneumonia vaccine for humanitarian organizations

Fight against HIV doomed to fail without urgent focus on West and Central Africa

MSF responds to Indian Health Ministry’s notification on ban of 344 Fixed Dose Combinations Drugs

MSF reaction to announcement of Merck and Gavi, the Vaccine Alliance for future Ebola outbreak preparedness

Central African Republic (CAR): MSF launches vaccination campaign of unprecedented scale

HIV: Despite better access to treatment, many AIDS patients in African hospitals still die

MSF reaction to latest UNAIDS report on global progress of scaling up life-saving HIV treatment

South Africa Should Override Patent on Key HIV Medicine After Widespread Stock Out Problem

MSF response on WHO guidance on malaria vaccine RTS,S

Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries

MSF response to START trial data showing all people with HIV should be treated immediately

MSF warns successful global HIV response will require bigger emphasis on adherence

Drug shortages threaten progress made in the world’s largest HIV programme

MSF kicks off global ████ to reduce the price of ████ to $5 in developing countries

MSF responds to Pfizer announcement of pneumococcal vaccine price reduction

Oxford University begins trial of possible Ebola treatment at MSF Treatment Centre in Liberia

As US FDA approves promising new HIV drug dolutegravir, MSF asks when people in developing countries will have access